RNTX Hisse Senedi Fiyat Grafiği
RNTX Fiyat
Rein Therapeutics Inc
$1.17
14.7%
$0.14
Kapanışta: May 06, 16:00:00 GMT-4
$1.16
-0.85%
$-0.01
Ön Piyasa: May 07, 06:59:33 GMT-4
Geri
Rein Therapeutics Inc (RNTX) Fiyat
Önemli İstatistikler
Önceki Kapanış
$1.02
Açılış fiyatı
$1.04
Günün Aralığı
$1.02 - $1.2
52 haftalık aralık
$1 - $2.4
İşlem hacmi
3.5M
Ort.Hacim
274.9K
Dividend yield
--
EPS (TTM)
-1.84
Piyasa Değeri
$32.5M
RNTX nedir?
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. The company is headquartered in Austin, Texas and currently employs 11 full-time employees. The company went IPO on 2017-06-29. The firm's lead product candidate, LTI-03 (idiopathic pulmonary fibrosis), is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Its second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions. LTI-01 has received Orphan Drug Designation in the United States and European Union and Fast Track Designation in the United States. Its pipeline also includes LTI-05 (cystic fibrosis).
